Orexigen Therapeutics (OREX)
Add to Watchlists Create an AlertOrexigen Therapeutics Fundamental Score
Orexigen Therapeutics Fundamental Score Chart
View Fundamental Score for OREX.
Start Your YCharts Pro Gold Membership.
Orexigen Therapeutics Historical Fundamental Score Data
Pro Data ExportThere is no data for the selected date range.
About Fundamental Score
The fundamental score is YCharts proprietary score of how strong a company's fundamentals are. It ranges from 1 to 10, with 10 being the strongest. The ten tests are as follows (score one point for each test the company passes):
1) EPS Growth > 0
2) Revenue Growth > 0
3) Five Year Average ROE > 5%
4) 10 Year Minimum Gross Margin > 0
5) Book Value Per Share Growth > 0
6) Current Ratio > 1
7) Debt to Equity Ratio < 13
8) 10 Year Average Cash Flow > 0
9) Long Term Debt < 5 x Net Income
10) Uninterrupted dividend payments as far back as we have data
(unless otherwise noted, growth rates are calculated for 10 years or the life of the stock, whichever is shorter)
Further details can be found in our support center article about the fundamental score.
Learn More
View Fundamental Score for OREX.
Start Your YCharts Pro Gold Membership.
Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle.
YCharts Pro is only $49/month, and comes with a 14-day free trial.
Get Started NowAlready a YCharts Pro Gold Member? Sign in here.
OREX Fundamental Score Benchmarks
| Companies | |
|---|---|
| Arena Pharmaceuticals | Go Pro |
| Vivus | Go Pro |
| Sucampo Pharmaceuticals | Go Pro |
OREX Fundamental Score Rankings
| Overall |
72nd percentile 2233 of 8009 |
| Sector |
71st percentile 194 of 687 in Healthcare |
| Industry |
66th percentile 23 of 69 in Drug Manufacturers - Specialty & Generic |
OREX Fundamental Score Range, Past 5 Years
| Minimum | Go Pro | Dec 2009 |
| Maximum | Go Pro | Dec 2012 |
| Average | Go Pro |
